Oberoi S, Xue W, Qumseya A, Scharschmidt T, Binitie O, Sorger JI, Kumar KA, Wong K, Donaldson SS, Teot L, Rudzinski ER, Venkatramani R. Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children’s Oncology Group trials. Cancer. 2025 Jun 15;131(12):e35929. doi: 10.1002/cncr.35929. PMID: 40464368; PMCID: PMC12135461.
Study ID Citation
Abstract
Long‐term survival and prognostic factors for patients with extremity rhabdomyosarcoma (RMS) treated on contemporary Children’s Oncology Group (COG) trials are unknown. Data of extremity RMS patients enrolled on COG trials from 1998 to 2014 were analyzed to estimate event‐free survival (EFS) and overall survival (OS), and factors associated with survival.